These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3898421)

  • 21. [Behavior of adenosine and adenosine triphosphatase phosphoric esters in systemic histiocytic sarcomatoses].
    Mandelli F; Fontana L; Papa G; De Laurenzi A
    Riv Emoter Immunoematol; 1967; 14(5):221-44. PubMed ID: 4244545
    [No Abstract]   [Full Text] [Related]  

  • 22. Beta-2-microglobulin review: its relevance in clinical oncology.
    Cooper EH; Plesner T
    Med Pediatr Oncol; 1980; 8(4):323-34. PubMed ID: 6161299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serum alpha 2 H in malignant hemopathies and cirrhosis. Prognostic value].
    Martin JP; Charlionet R; Ropartz C
    Presse Med (1893); 1971 Nov; 79(51):2313-6. PubMed ID: 4108548
    [No Abstract]   [Full Text] [Related]  

  • 24. The behaviour of beta-2-microglobulin in acute and chronic leukaemias.
    Schena FP; Liso V; Losuriello V; Mera S; Bonomo L
    Biomedicine; 1980 Feb; 33(1):12-5. PubMed ID: 6154490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Behavior of various erythrocyte enzymes of the anaerobic glycolytic pathway in systemic histocytic sarcomatoses].
    De Laurenzi A; Fontana L; Papa G
    Riv Emoter Immunoematol; 1967; 14(5):197-219. PubMed ID: 5264421
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum beta 2-microglobulin in lymphoproliferative and myeloproliferative diseases.
    Child JA; Kushwaha MR
    Hematol Oncol; 1984; 2(4):391-401. PubMed ID: 6396193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value of serum and urinary lysozyme estimation in malignant hemopathies.
    Bruckner I; Serban M
    Med Interne; 1980; 18(2):149-54. PubMed ID: 6930691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum beta 2 microglobulin concentration in patients with multiple myeloma].
    Mendek-Czajkowska E
    Acta Haematol Pol; 1984; 15(3-4):161-5. PubMed ID: 6399429
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical significance of the monoclonal macroglobulinemias].
    Corral Corral C; Pérez Peña F; Schüller Pérez A
    Rev Clin Esp; 1984 Apr; 173(1):1-7. PubMed ID: 6429750
    [No Abstract]   [Full Text] [Related]  

  • 30. The fibrinolytic enzyme system in haematological malignancy.
    Dawson AA; Ogston D; Douglas AS
    Bibl Anat; 1973; 12():272-8. PubMed ID: 4597632
    [No Abstract]   [Full Text] [Related]  

  • 31. [Beta 2 microglobulin in lymphoproliferative status].
    Schaimberg L; Ikeda F; Cordeiro M; Santos RA; Murakami S; Scheinberg MA
    Rev Paul Med; 1987; 105(3):183-4. PubMed ID: 3329760
    [No Abstract]   [Full Text] [Related]  

  • 32. Hormonal changes in patients with haematological malignancies.
    Pavelic K; Pekic B; Gabrilovac J; Bratic-Mikes V; Boranic M
    Biomedicine; 1981 Nov; 35(6):181-4. PubMed ID: 6279194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on human alpha 1-microglobulin XIII. Serum alpha 1-microglobulin in various immunoglobulinopathies. Binding of alpha 1-microglobulin with monoclonal IgA].
    Itoh Y; Enomoto H; Kawai T
    Rinsho Byori; 1984 Oct; 32(10):1125-9. PubMed ID: 6084078
    [No Abstract]   [Full Text] [Related]  

  • 34. [Chromosome abnormalities during chronic lymphoid leukemia, malignant lymphoreticular process and Kahler's disease].
    Broustet A; Meuge C; Legrand E
    Nouv Rev Fr Hematol; 1970; 10(1):91-9. PubMed ID: 4246339
    [No Abstract]   [Full Text] [Related]  

  • 35. Malignant lymphoma and lymphatic leukemia associated with myeloma-type serum proteins.
    AZAR HA; HILL WT; OSSERMAN EF
    Am J Med; 1957 Aug; 23(2):239-49. PubMed ID: 13444306
    [No Abstract]   [Full Text] [Related]  

  • 36. Erythrocyte sensitivity to in-vitro lysis in leukaemia.
    Catovsky D; Lewis SM; Sherman D
    Br J Haematol; 1971 Nov; 21(5):541-50. PubMed ID: 5286440
    [No Abstract]   [Full Text] [Related]  

  • 37. [The prognostic significance of the beta 2-microglobulin level of the blood serum in multiple myeloma patients].
    Lubo-Lesnichenko IF; Bessmel'tsev SS; Abdulkadyrov KM; Blinov MN; Stel'mashenko LV
    Ter Arkh; 1996; 68(10):28-31. PubMed ID: 9026938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum ferritin in haematologic malignancies.
    Eyetsemitan W; Oluboyede OA
    East Afr Med J; 1986 May; 63(5):350-4. PubMed ID: 3461934
    [No Abstract]   [Full Text] [Related]  

  • 39. beta 2 microglobulin in lymphoproliferative disorder.
    Spati B; Cooper EH; Child JA
    Lancet; 1978 Oct; 2(8095):897-8. PubMed ID: 81446
    [No Abstract]   [Full Text] [Related]  

  • 40. Paraprotein and beta2-microglobulin analyses in multiple myeloma--do we need to monitor both?
    Sinclair D; Cranfield T; Ganczakowski M
    Clin Lab; 2003; 49(3-4):129-34. PubMed ID: 12705694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.